AlphaHunt
Healthcare

ILMN Stock Analysis

Illumina, Inc. · current price $159.10 (-3.05% today)

★★★ Average 60/ Alpha Score
Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
LAST EARNINGS Illumina, Inc. (ILMN)

Latest earnings

EPS
$1.19 vs $1.01 est · +0.2% vs estimate BEAT
Revenue
$1.09B · +3.0% YoY
Stock reaction (1M)
+12.1%
Beat streak
4 of last 4 quarters

Key metrics

Alpha Score
60/100
Grade
C
Rev Growth YoY
+4.8%
30-day Momentum
+12.1%
Forward P/E
28.8×
Analyst Target
$147.17
Implied Upside
-7.5%

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA HOLX

View all Healthcare stocks →

ILMN — frequently asked

What is ILMN's Alpha Score?

Illumina, Inc. (ILMN) currently has a TickerMover Alpha Score of 60/100, rated ★★★ Average. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Illumina, Inc. (ILMN) a buy?

TickerMover does not give buy or sell recommendations. ILMN scores 60/100 (★★★ Average) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is ILMN's score updated?

ILMN's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for ILMN →
TickerMover is a research tool, not financial advice. Alpha Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.
Questions? support@tickermover.com